loadpatents
name:-0.02667498588562
name:-0.029661178588867
name:-0.004601001739502
Melvin, JR.; Lawrence S. Patent Filings

Melvin, JR.; Lawrence S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Melvin, JR.; Lawrence S..The latest application filed is for "rapamycin for the treatment of lymphangioleiomyomatosis".

Company Profile
4.30.23
  • Melvin, JR.; Lawrence S. - Niwot CO
  • Melvin, Jr.; Lawrence S. - Longmont CO
  • Melvin, Jr.; Lawrence S. - Ledyard CT
  • Melvin, Jr.; Lawrence S. - Gales Ferry CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Rapamycin For The Treatment Of Lymphangioleiomyomatosis
App 20220054410 - Lichenstein; Henri ;   et al.
2022-02-24
Rapamycin for the treatment of lymphangioleiomyomatosis
Grant 11,123,289 - Lichenstein , et al. September 21, 2
2021-09-21
Apoptosis signal-regulating kinase inhibitors
Grant RE48,711 - Corkey , et al. August 31, 2
2021-08-31
Inhalable rapamycin formulation for treating age-related conditions
Grant 11,103,449 - Armer , et al. August 31, 2
2021-08-31
Inhalable Rapamycin Formulation For Treating Age-related Conditions
App 20210212942 - Armer; Thomas ;   et al.
2021-07-15
Inhalable Rapamycin Formulation For The Treatment Of Pulmonary Hypertension
App 20200306230 - Armer; Thomas ;   et al.
2020-10-01
Rapamycin For The Treatment Of Lymphangioleiomyomatosis
App 20200276120 - Lichenstein; Henri ;   et al.
2020-09-03
Rapamycin for the treatment of lymphangioleiomyomatosis
Grant 10,307,371 - Armer , et al.
2019-06-04
Rapamycin for the treatment of lymphangioleiomyomatosis
Grant 10,307,370 - Lichenstein , et al.
2019-06-04
Inhalable Rapamycin Formulation For Treating Age-related Conditions
App 20190133938 - Armer; Thomas ;   et al.
2019-05-09
Rapamycin For The Treatment Of Lymphangioleiomyomatosis
App 20180200184 - Armer; Thomas ;   et al.
2018-07-19
An Inhalable Rapamycin Formulation For The Treatment Of Pulmonary Hypertension
App 20170304276 - Armer; Thomas ;   et al.
2017-10-26
Apoptosis Signal-regulating Kinase Inhibitors
App 20170196844 - GRAUPE; MICHAEL ;   et al.
2017-07-13
Apoptosis signal-regulating kinase inhibitors
Grant 9,586,932 - Graupe , et al. March 7, 2
2017-03-07
Rapamycin for the Treatment of Lymphangioleiomyomatosis
App 20160235668 - Rothberg; Jonathan M. ;   et al.
2016-08-18
Apoptosis Signal-regulating Kinase Inhibitors
App 20160130251 - Graupe; Michael ;   et al.
2016-05-12
Rapamycin For The Treatment Of Lymphangioleiomyomatosis
App 20150265582 - Armer; Thomas ;   et al.
2015-09-24
Apoptosis signal-regulating kinase inhibitors
Grant 9,067,933 - Corkey , et al. June 30, 2
2015-06-30
Apoptosis Signal-regulating Kinase Inhibitors
App 20140018370 - Corkey; Britton Kenneth ;   et al.
2014-01-16
Apoptosis signal-regulating kinase inhibitors
Grant 8,598,360 - Corkey , et al. December 3, 2
2013-12-03
Apoptosis signal-regulating kinase inhibitors
Grant 8,552,196 - Corkey , et al. October 8, 2
2013-10-08
Apoptosis signal-regulating kinase inhibitors
Grant 8,378,108 - Corkey , et al. February 19, 2
2013-02-19
Apoptosis Signal-regulating Kinase Inhibitors
App 20130035339 - Corkey; Britton ;   et al.
2013-02-07
Apoptosis Signal-regulating Kinase Inhibitors
App 20130012521 - Corkey; Britton ;   et al.
2013-01-10
Metabolites and derivatives of ambrisentan
Grant 8,217,155 - Melvin, Jr. , et al. July 10, 2
2012-07-10
Cycloalkylidene and heterocycloalkylidene inhibitor compounds
Grant 8,198,299 - Melvin, Jr. , et al. June 12, 2
2012-06-12
Fused heterocyclyc inhibitor compounds
Grant 8,124,764 - Melvin, Jr. , et al. February 28, 2
2012-02-28
Cycloalkylidene And Heterocycloalkylidene Inhibitor Compounds
App 20120045412 - Melvin, JR.; Lawrence S. ;   et al.
2012-02-23
Cycloalkylidene and heterocycloalkylidene inhibitor compounds
Grant 8,088,771 - Melvin, Jr. , et al. January 3, 2
2012-01-03
Imidazopyridinyl Thiazolyl Histone Deacetylase Inhibitors
App 20110052527 - Melvin, JR.; Lawrence S. ;   et al.
2011-03-03
Apoptosis Signal-regulating Kinase Inhibitors
App 20110009410 - Corkey; Britton ;   et al.
2011-01-13
Benzofuran Anilide Histone Deacetylase Inhibitors
App 20100292320 - Melvin, JR.; Lawrence S.
2010-11-18
Metabolites And Derivatives Of Ambrisentan
App 20100204163 - Melvin, JR.; Lawrence S. ;   et al.
2010-08-12
Fused Heterocyclyc Inhibitor Compounds
App 20100029638 - Melvin, JR.; Lawrence S. ;   et al.
2010-02-04
Cycloalkylidene And Heterocycloalkylidene Inhibitor Compounds
App 20100022543 - Melvin, JR.; Lawrence S. ;   et al.
2010-01-28
Imidazopyridinyl Thiazolyl Histone Deacetylase Inhibitors
App 20090005374 - Melvin, JR.; Lawrence S. ;   et al.
2009-01-01
Substituted tetralins, chromans and related compounds in the treatment and related compounds in the treatment of asthma, arthritis and related diseases
Grant 5,998,451 - Eggler , et al. December 7, 1
1999-12-07
Benzopyran and related LTB.sub.4 antagonists
Grant 5,550,152 - Koch , et al. August 27, 1
1996-08-27
Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
Grant 5,384,318 - Eggler , et al. January 24, 1
1995-01-24
Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
Grant 5,059,609 - Eggler , et al. October 22, 1
1991-10-22
Bicyclic benzo fused pyran compounds used for nausea treatment and prevention
Grant 4,870,084 - Eggler , et al. September 26, 1
1989-09-26
Producing analgesia with pharmacologically active 2-hydroxy-4-(substituted) phenyl cycloalkanes derivatives
Grant 4,831,059 - Johnson , et al. May 16, 1
1989-05-16
3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor
Grant 4,391,827 - Harbert , et al. July 5, 1
1983-07-05
2-Hydroxy-4-(substituted) phenyl cycloalkanes and derivatives
Grant 4,371,720 - Johnson , et al. February 1, 1
1983-02-01
Intermediates for making 1-(3-benzyloxyphenyl)-1,1-dimethylheptane
Grant 4,360,700 - Melvin, Jr November 23, 1
1982-11-23
3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents
Grant 4,306,097 - Harbert , et al. December 15, 1
1981-12-15
1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
Grant 4,270,005 - Althuis , et al. May 26, 1
1981-05-26
1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
Grant 4,268,523 - Althuis , et al. May 19, 1
1981-05-19
3-[2,4-(Disubstituted)-phenyl]azacycloalkanones as analgesics
Grant 4,263,438 - Althuis , et al. April 21, 1
1981-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2025 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed